Biopharma Institute

Cortex Pharmaceuticals is a neuroscience firm that focuses on drug therapies for neurological and psychiatric disorders. The company s proprietary Ampakine compounds act to increase the strength of signals at connections between brain cells. Connection deficits are thought to be responsible for memory and behavior problems in Alzheimer s disease. Many psychiatric diseases, such as schizophrenia, occur as a result of imbalances in the brain s neurotransmitter system. Cortex has allied with N.V. Organon for the treatment of schizophrenia and depression. The company works with Les Laboratoires Servier for the development of its Ampakine compounds to treat the neurodegenerative effects associated with aging and disease, such as mild cognitive impairment, Alzheimer s disease and anxiety disorders. The company s Ampakine technology also aims to improve conditions associated with autism, stroke, and traumatic brain and spinal cord injuries. Cortex Pharmaceuticals is headquartered in Irvine, Calif.

Ash Ingredients Inc, located in Glen Rock, NJ, is a global leader in the production and distribution of innovative and high-quality custom-engineered organic intermediates, fine chemicals, and advanced pharmaceutical intermediates. With over two decades of experience, the company serves leading corporations in the pharmaceutical, personal care, and nutraceutical industries, leveraging advanced technical expertise and a commitment to confidentiality. The company’s dedicated research and development facility focuses on the custom synthesis of highly advanced intermediates and process optimization. Ash Ingredients Inc also offers comprehensive solutions, including third-party logistics and warehousing, ensuring a hassle-free service that delivers optimum value to its customers. Generated from the website